FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAY, B. K.
Right arrow Articles by SUDOL, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAY, B. K.
Right arrow Articles by SUDOL, M.
(The FASEB Journal. 2000;14:231-241.)
© 2000 FASEB

The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains

BRIAN K. KAY*1, MICHAEL P. WILLIAMSON{dagger} and MARIUS SUDOL{ddagger}

* Department of Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin 53706-1532, USA;
{dagger} Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom;
{ddagger} Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA

1Correspondence: Department of Pharmacology, University of Wisconsin, 1300 University Ave., Madison, WI 53706-1532, USA. E-mail: bkkay{at}facstaff.wisc.edu


   ABSTRACT
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
Acommon focus among molecular and cellular biologists is the identification of proteins that interact with each other. Yeast two-hybrid, cDNA expression library screening, and coimmunoprecipitation experiments are powerful methods for identifying novel proteins that bind to one’s favorite protein for the purpose of learning more regarding its cellular function. These same techniques, coupled with truncation and mutagenesis experiments, have been used to define the region of interaction between pairs of proteins. One conclusion from this work is that many interactions occur over short regions, often less than 10 amino acids in length within one protein. For example, mapping studies and 3-dimensional analyses of antigen–antibody interactions have revealed that epitopes are typically 4–7 residues long (1) . Other examples include protein-interaction modules, such as Src homology (SH) 2 and 3 domains, phosphotyrosine binding domains (PTB), postsynaptic density/disc-large/ZO1 (PDZ) domains, WW domains, Eps15 homology (EH) domains, and 14–3-3 proteins that typically recognize linear regions of 3–9 amino acids. Each of these domains has been the subject of recent reviews published elsewhere (2 3 4 5 6 7) . Among the primary structures of many ligands for protein–protein interactions, the amino acid proline is critical. In particular, SH3, WW, and several new protein-interaction domains prefer ligand sequences that are proline-rich. In addition, even though ligands for EH domains and 14–3-3 domains are not proline-rich, they do include a single proline residue. This review highlights the analysis of those protein–protein interactions that involve proline residues, the biochemistry of proline, and current drug discovery efforts based on proline peptidomimetics.—Kay, B. K., Williamson, M. P., Sudol, M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.


   SH3 DOMAINS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
SH3 DOMAINS ARE 50–70 amino acids long and often present in eukaryotic signal transduction and cytoskeletal proteins such as Abl, actin-binding protein, Bem1, cdc25, cortactin, calcium channel ß1B2 subunit, Grb2, myosin, Nck, PI3K regulatory subunit, PLC{gamma}, ras GTPase activator, spectrin, and tight junction protein ZO-1. Computer-aided analysis of protein sequences has even suggested that SH3 domains may also exist in bacteria (7a) . For a long time, the function of the SH3 domain in eukaryotes was enigmatic; however, since the domain was present in so many cytoskeletal proteins, it was assumed to play a role in mediating protein–protein interactions (8) or directing cell compartmentalization (9) . The SH3 domain clearly had an important function for some proteins, as mutations in the SH3 domains of cellular Src (10) and Abl (11 , 12) are activating.

The ligand specificity of SH3 domains was first revealed when a {lambda}-cDNA expression library was screened with a glutathione S-transferase (GST)-Abl SH3 fusion protein (13) . Two different cDNA clones were isolated and the regions responsible for their binding to the Abl SH3 domain were shown to be proline-rich segments (14) . Examination of other SH3 ligands identified in the same manner (15 16 17) has suggested that SH3 domains recognize proline-rich sequences containing the core PxxP, where x denotes any amino acid (18 , 19) .

With the advent of combinatorial peptide libraries, ligand specificity has been determined rapidly for a large number of different SH3 domains. The SH3 domains of Src and the phosphatidyl inositol 3-kinase (PI3K) regulatory subunit select proline-rich sequences from peptides displayed on beads (20) and phage (21 22 23) . Phage libraries have also been used to identify the specificity of SH3 domains from Abl, amphiphysin I, cortactin, Crk, Fyn, Grb2, Lyn, Nck, p53BP2, PI3K, PLC{gamma}, Tsk, and Yes (22 , 24 25 26 27) . The optimal ligand preference for each domain varies around the PxxP core (Table 1 ), demonstrating that a great deal of protein–protein interaction specificity can be encoded by proline-rich sequences.


View this table:
[in this window]
[in a new window]
 
Table 1. Protein-rich sequences that bind to specific protein interaction modulesa

Investigations into the structure of peptide-SH3 complexes have shown that peptide ligands can bind in two orientations with respect to the SH3 domain (28 , 29) . The peptides, which bind in either an N to C or C to N terminal orientation relative to the SH3 domain, have been classified as either class I or class II ligands, respectively. The orientation of the peptide is dictated by the location of a positively charged residue, relative to the PxxP core, which forms a salt bridge with an acidic residue in the SH3 domain (Fig. 1A ). Thus, peptides with the motif +xxPxxP and PxxPx+ (where + refers to a positively charged amino acid) correspond to class I and class II motifs, respectively. Some SH3 domains, like that present in Src, have the capacity to bind peptides of either class (i.e., RPLPPLP and PPVPPR; where the scaffolding prolines are underlined), although the biological implications of this are unclear. (One frequently raised possibility is that ligand binding in two orientations could access different partners in multicomponent protein complexes.) In both orientations, not only do proline and leucine side-chains fit into the same hydrophobic pockets on the SH3 domain (Fig. 1A ), but also very similar hydrogen bonds can be made from peptide carbonyls in the proline-rich ligand (30) . Typically, the Kd values of synthetic peptides binding SH3 domains are 1–100 µM, although amino acid analoging experiments have led to the development of higher affinity peptide ligands (31) . The Kdvalues of full-length proteins that interact with SH3 domains are significantly lower than for peptides; for example, the HIV Nef protein binds to the Hck SH3 domain with a Kd of ~250 nM (32) .



View larger version (58K):
[in this window]
[in a new window]
 
Figure 1. A) Three-dimensional model of how class I and II ligands bind to SH3 domains, based on the structure of the Src SH3 domain (28) . The protein’s topological surface is shown in gray, with acidic residues colored in blue. The ligands are RALPPLPRY, a class I ligand (below) and AFAPPLPRR, a class II ligand (above). All residues in the ligands are colored gray, except for the recognition prolines (yellow), flanking prolines (cyan), leucine (brown), and arginine (red). The side-chain of the first arginine in the class II ligand has been omitted for clarity. The peptides interact with the two LP dipeptide pockets (left and center) and the acidic specificity pocket (right), which form grooves in the surface separated by ridges. The NH2- and carboxyl-termini of the peptides are denoted with N and C, respectively. B) Three-dimensional model of how peptide ligands bind to the YAP65 WW domain. The protein’s topological surface is shown in white, with three of the key residues shown in green (from left to right, Trp39, Tyr28, and Leu30). The peptide ligand is shown in gray, except for the core prolines (yellow), which sit in a shallow pocket formed by Trp39 and Tyr28, the flanking prolines (cyan), and the tyrosine (red), which sits over the hydrophobic pocket containing Leu30. C) A space-filling model of a polyproline helix, colored as green, carbon; red, oxygen; blue, nitrogen; white, hydrogen.

There are three shallow pockets within the SH3 domain where the peptide ligands bind. Two of the pockets are 25 Å long and 10 Å wide, large enough to accommodate each of the prolines in the PxxP motif, accompanied by a hydrophobic residue (i.e., A, I, L, V, and P). These two pockets are parallel to each other and have been termed the ‘LP dipeptide pockets’ (33) . A third pocket, termed the ‘specificity pocket’ is bound by two loops (i.e., RT, nSrc) of the SH3 domain (34) . Within this pocket sit residues either NH2- or carboxyl-terminal of the positively charged residue in class I or class II ligands, respectively.

Besides the two orientations described above, a third SH3 ligand corresponding arrangement has been described. In this arrangement, residues spaced apart in a protein sequence come together, because of the tertiary structure of the protein, to interact with the peptide-binding groove of the SH3 domain. One example of this arrangement occurs within the p53 binding protein, p53BP2. The SH3 domain of p53BP2 interacts with two segments of the L3 loop of p53, in a manner analogous to the contacts made in canonical SH3-PxxP complexes, with the positions and orientations of the interacting residues determined by the overall 3-dimensional structure of p53, rather than as part of a PxxP core (35) . It should be mentioned that p53 does contain two PxxP motifs that have been shown to be involved in growth suppression through interactions with other SH3 domain-containing cellular proteins (36) .

Recently, a novel ligand sequence has been observed for the SH3 domain of the epidermal growth factor receptor substrate, Eps8, which has been discovered to form intertwined dimers (37) . Because the site of dimerization includes the interface of the SH3 domain that typically interacts with PxxP motifs, the specificity of the intertwined dimers is altered. Analysis of the ligand preferences of this dimer has revealed it to recognize not PxxP, but PxxDY instead (37a) . It will be interesting to learn how common this unusual arrangement is among other SH3 domains.

Analysis of several SH3 domain interactions has suggested that some form stable complexes and others may be regulated in the cell. For example, the interaction between Sos and Grb2, which is constitutively complexed in cells, can be inhibited by phosphorylation of serine/threonine residues in the proline-rich carboxyl-terminal segment of Sos, after receptor activation (38) . Phosphorylation of a PxxP site in the Wiskott-Aldrich syndrome protein (WASP) can inhibit its interaction with the SH3 domain of the cytoskeletal-associated protein, PSTPIP (39) . Although the sites have not been mapped, phosphorylation of the Drosophila-enabled (Ena) protein by Abl can inhibit the interaction of Ena with certain SH3 domains (40) . Finally, binding of phosphopeptide ligands to the Crk SH2 domain alters its conformation such that a proline-rich insert in the Crk SH2 domain becomes an SH3 domain-binding site (41) . Very likely, the interaction between other SH3 domains and ligand-containing proteins is regulated by allosteric changes (42) . A recent publication capitalizes on this conclusion by generating temperature-sensitive SH3 domains for the purpose of dissecting SH3 domain function in vivo (43) . Such an approach may be applicable to other protein interaction modules.

Although most SH3 domain-mediated interactions are intermolecular, several intramolecular interactions have been described. In Src (44 , 45) , Hck (46 , 47) , and Abl (48) , the SH3 domains interact with a linker region between the SH2 and catalytic kinase domains of these proteins, thereby adopting a catalytically inactive conformation (49) . In some cases, this conformation is stabilized by the interaction of the SH2 domain with phosphorylated tyrosine residues present near the carboxyl termini of such proteins. The elucidation of these various intramolecular interactions explains the observations that mutations in the SH3 domains of Src (10) and Abl (50) are activating, because the mutant forms fail to adopt an inactive conformation. Another example occurs in the cellular oncogene, Itk, where a proline-rich sequence, KPLPPTP (residues 155–160) binds to an SH3 domain (residues 170–232) within the same protein (51) . The intramolecular interaction is quite stable, even without the involvement of an SH2 domain, although the interaction of the Itk SH3 domain with a soluble form of the KPLPPTP peptide sequence is undetectable.


   WW DOMAINS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
WW domains are small globular modules composed of 38–40 amino acids. The name refers to two conserved tryptophan (W) residues that are spaced 20–22 amino acids apart and play an important role in the structure and function of the domain (52) . The WW domain was initially identified by computer-aided analysis of imperfectly repeated sequences in the murine form of Yes-associated protein (YAP; http://www.bork.embl-heidelberg.de/Modules.ww-gif.html). Although the WW domain resembles the SH3 domain functionally by displaying affinity toward proline-rich ligands, their structures are distinct (53 54 55) . WW domains have an antiparallel three-stranded ß-sheet structure that forms a shallow binding pocket for ligands containing PPxY or PPLP core motifs, usually flanked by additional prolines (53 , 56 , 57) . Recently another motif, with a preliminary consensus PxxGMxPP (Table 1) , was proposed for ligands interacting with a subset of WW domains present in proteins participating in the pre-mRNA splicing machinery (58) . These WW domains have a distinguishing feature of three consecutive tyrosine residues located centrally within them.

The first structure of a WW domain was that of human YAP in complex with its cognate ligand, solved by Nuclear Magnetic Resonance spectroscopy (54) . Shortly thereafter, the structure of Pin1 WW domain was solved by X-ray (59) . These two structures are almost completely superimposable. The WW domain is the most compact globular structure known to occur naturally, and it is the smallest ß-sheet module that folds as a monomer in solution without disulfide bridges or cofactors (60) . The hallmarks of the binding pocket of the WW domain of human YAP include three hydrophobic amino acids, leucine, tyrosine, the second conserved tryptophan and histidine, as confirmed by structural and mutational studies (54) . Two prolines of the ligand (PPxY) form van der Waals contacts with the second tryptophan, whereas the terminal tyrosine of the ligand fits into a hydrophobic pocket and is coordinated by a hydrogen bond from the conserved histidine residue (Fig. 1B ). The Kd of interaction for WW-ligand complex formation is in the high nM to low µM values for proline-rich ligands, and in the low µM values for phosphoserine or phosphothreonine containing ligands, depending upon the domain-ligand pair, buffer conditions, and the binding assay (57 , 61 , 62) . Phosphorylation of the terminal tyrosine in the ligand (PPxY) abolishes the binding in vitro, suggesting that this modification could represent a negative regulation mechanism for a subset of WW domains in vivo (63) .

Immediately after its discovery, the WW domain attracted attention because the signaling complexes it mediates have been implicated directly or indirectly in several human diseases including Liddle’s syndrome of hypertension, muscular dystrophy, and Alzheimer’s and Huntington’s diseases (64 65 66 67 68 69) . Liddle’s syndrome results from genetic lesions that affect ß and {gamma} subunits of the amiloride-sensitive epithelial sodium channel (70) . Most of the mutations that have been reported in patients with Liddle’s syndrome represent deletions that encompass a minimum of 12 residues, which includes the PPxY motif. Three independent Liddle’s syndrome patients were recently characterized who have single-point mutations in one of the three crucial positions of the PPxY motif in the ß subunit of the sodium channel (70 71 72) . These mutations (i.e., P615S, P616L, and Y618H) substantiate biologically the conclusions first generated by in vitro alanine scanning of a short region within YAP WW domain interacting proteins (53 , 63) . Liddle’s mutations abolish binding of sodium channel subunits to the Nedd-4 protein, which in addition to containing three WW domains includes an ubiquitin-ligase catalytic domain (66 , 73 , 74) . Nedd-4 normally participates in targeting the epithelial sodium channel subunits for ubiquitin-directed proteolysis, but in mutant epithelial cells the channel has a long half-life, leading to a sodium imbalance and subsequently high blood pressure. Given that epithelial sodium channels are phosphorylated on serine, threonine, and possibly tyrosine residues, it will be interesting in the future to learn whether or not these modifications modulate the interaction between the sodium channel and the WW domains of Nedd-4 and thereby change the rate of channel degradation (75 , 76) .

Recently, the PPxY motif has been observed in a number of transcription factors (i.e., c-Jun, AP2, NF-E2, C/EBP{alpha}, PEBP2/CBF) where it may play a role in transcriptional activation. For example, the hematopoietic transcription factor, NF-E2, contains two PPxY motifs that can be recognized by the WW domains contained within certain ubiquitin ligases (61 , 77) . Interaction of WW domain-containing proteins with this motif is likely to be important for transcriptional activation, as deletion of one of the two PPxY motifs in NF- E2 (61) or the single copy in PEBP2 (78) inhibits their ability to transactivate genes. Thus, the presence of the PPxY motif within transcription factors may function to recruit WW domain-containing proteins such as YAP (78) and Npw38 (79) , which have been discovered to act as transcriptional coactivators. Conversely, it is possible in some cases that WW domain-containing proteins serve to negatively regulate transcription. Recently, PQBP-1, a novel polyglutamine tract binding protein with a WW domain, has been shown to inhibit transcription activation by Brn-2, although the role of its WW domain is yet to be defined (80) .


   OTHER MODULES/PROTEINS THAT BIND PROLINE-RICH LIGANDS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
The number of modules that bind proline-rich ligands is increasing (81) . The EVH1 (Enabled, VASP, Homology 1) domain is a protein interaction module present in Ena, vasodilator-stimulated phosphoprotein (VASP), and the WASP family of proteins that regulate the dynamics of the actin cytoskeleton (82 83 84 85) . EVH1 domains bind the proline-rich consensus sequence (D/E)FPPPP, which is present in ActA, a protein on the surface of the bacterial pathogen Listeria monocytogenes as well as in vinculin and zyxin, two protein components of focal adhesions (84) . The EVH1 domain has also been detected in Homer, a neuronal protein enriched in excitatory synapses (86) , and which binds to proline-rich motifs (i.e., PPxxF) within glutamate and inositol trisphosphate receptors (86 87 88) and Shank, a postsynaptic density protein (89) . Recently, the 3-dimensional structure of the EVH1 domain has been solved for the mouse Ena protein (90) . Much like SH3 and WW domains, aromatic residues within the EVH1 domain create an interaction surface for proline-rich peptide ligands that adopt a polyproline II (PP II) conformation (see below), even though the binding site is V-shaped instead of flat.

Two other proteins that bind proline-rich peptides should be mentioned as well. A cytosilic protein, CD2 binding protein (CD2BP2), was recently described in a pathway that regulates CD2-triggered T lymphocyte (91) . The CD2BP2 protein contains a domain that was shown to interact with a tandemly repeated PPPGHR sequence (Table 1) and its structure was recently solved (91a) . Profilin was originally described as a regulator of actin polymerization (92) . Within its structure, profilin, like SH3, WW, and EVH1 domains, exposes stacked aromatic and hydrophobic residues to form an interface that binds proline-rich ligands (82 , 93 , 94) . The binding of polyproline has been shown to be essential for profilin function (95) ; profilin require a minimum of 6–8 consecutive prolines for high affinity (92 , 94 , 96) . Some of these cores are flanked by leucines, providing a basis for speculation about degeneracy of certain proline-rich ligands that might interact with both profilin and SH3 and WW domains with similar affinities (81 , 94 , 97) . Indeed, it has been speculated that profilin may provide the link between signaling pathways and remodeling of the actin cytoskeleton (98) , a good example of the versatile biological role made possible by the promiscuity exhibited by proline-rich regions and their ligands.


   BIOPHYSICAL REASONS WHY PROLINE IS A COMMON BINDING MOTIF
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
Proline is unique among the 20 common amino acids in having the side-chain cyclized onto the backbone nitrogen atom. This means that the conformation of proline itself is limited, with backbone {phi} angles of ~-65°. It also restricts the conformation of the residue preceding the proline because of the bulk of the N-substituent and results in a strong preference for a ß-sheet conformation (99) . As a consequence, polyproline sequences tend to adopt the PP II helix, which is an extended structure with three residues per turn. This implies that the two prolines in the SH3 domain ligand core, PxxP, are on the same face of the helix and are thus well placed to interact with the protein. The PP II helix is an unusual structure: the prolines form a continuous hydrophobic strip round the surface of the helix, while the backbone carbonyls present ideal hydrogen bonding sites, being both conformationally restricted (and therefore poorly hydrated) and electron-rich (Fig. 1C ). Therefore, PP II helices present an easily accessible hydrophobic surface, as well as a good hydrogen-bonding site. The accessibility of PP II helices is greatly enhanced by the fact that they are frequently found either at the NH2- or carboxyl termini of proteins where they form extended structures that have been described as ‘sticky arms’ (100) .

PP II helices are common in globular proteins with solved 3-dimensional structures (101) , where they are generally solvent exposed and amphipathic (102) . They are probably even more common in proteins that have not been characterized structurally, because they tend to occur in extended regions that are hard to characterize using X-ray diffraction or NMR spectroscopy. It does not require an unbroken sequence of prolines to make a PP II helix; in fact, this type of left-handed helix can form in globular proteins without protein in the helix (101) . By contrast, a single nonproline residue may be enough to interrupt a PP II helix in a completely exposed chain (103) , and it has commonly been observed that the flanking prolines around or within the core PxxP SH3 ligand sequence function to maintain the required PP II structure (104) .

The relative rigidity of polyproline stretches means that they lose little conformational entropy on binding and thus bind more favorably than other exposed (i.e., nonglobular) peptide sequences. Of course, proline-rich sequences cannot bind as tightly as globular domains can; however, weaker binding can be of great advantage, as it allows the binding of proline-rich regions to be modulated rapidly. It also permits large changes to be made in Kd by small changes in the sequence of the proline-rich sequence or of its binding domain, either by sequence changes or by covalent modification such as phosphorylation. The entropic stabilization has been estimated to be ~1 kcal mol-1 per amino acid, both experimentally (105) and theoretically (100) . The interaction is largely hydrophobic and, therefore, does not require highly complementary surfaces. This accounts for the large sequence variability seen in polyproline binding and for the remarkable ability, described above, of SH3 domains to bind polyproline sequences in both orientations, two features that give proline-rich ligands great versatility in signaling pathways (30) .

Because proline-rich regions are exposed, their on-rates and off-rates for binding can be very fast. However, the price to be paid for these fast rates is that the complexes are not structurally very well defined on a nanometer scale. Therefore, proline-rich sequences are commonly found in situations requiring the rapid recruitment or interchange of several proteins, such as during initiation of transcription, signaling cascades, and cytoskeletal rearrangements. Here, the role of proline-rich regions is not to provide a structurally defined complex but rather to bring proteins together in such a way that subsequent interactions are more probable. For example, the proline-rich region on Sos1 binds to the two SH3 domains of Grb2, thereby bringing Sos1 to the cell membrane following receptor activation, where Sos1 in turn then activates the Ras pathway (100) . It is significant that the proline-rich protein is part of an ‘adaptor’ system bringing together other proteins. Proline-rich regions also seem to participate in other such adaptor systems, for example, in synaptic vesicle endocytosis (106) .

Some proteins contain tandem proline-rich repeats. These generally seem to have a different function, in that they are involved in the formation of networks of interactions that lead to precipitation or rigid meshes, as, for example, in salivary protein/polyphenol interactions or insect eggshells (100). An interesting role of multiple repeats appears to be in the actin-based movement of Listeria monocytogenes, where each repeat, within the EVH1 domain of ActA, contributes to the rate of actin-based movement (107). This latter provides yet another example of the ‘adaptor’ role of proline-rich regions. The binding of ActA (as well as zyxin and vinculin) to VASP and of VASP to profilin are both mediated by proline-rich regions, thus using proline-rich ligands indirectly to bring together ActA and actin (82).


   THE REGULATION OF PROLINE-DEPENDENT INTERACTIONS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
We still have much to learn about the regulation of the interactions mediated by proline-rich regions. It is clear that an important mechanism is provided by intramolecular ligands, as described above for SH3 domains (42) . Because an intramolecular interaction is generally more energetically favorable than the equivalent intermolecular interaction, the manipulation of intramolecular interactions, by conformational change or phosphorylation, is likely to be common.

Phosphorylation is a very common mechanism for regulation of protein function and is used extensively in the context of proline-rich regions (108) . Proline-rich regions often contain serine or threonine, which frequently occur as the residue immediately preceding the proline. Specific enzymes control phosphorylation and dephosphorylation: for example, the microtubule-associated protein 2 (MAP2) is developmentally regulated by phosphorylation, which controls its binding to tubulin via a proline-rich region (109) . Both MAP2 kinase and p34cdc2 (108) have a preference for the sequence Px(S/T)P, in which the two prolines are separated by two residues, suggesting that the proline-dependent kinase may well be recognizing a PP II conformation in the substrate. As noted above, some WW domain ligands represent target sites for proline-directed serine-threonine kinases and have a phosphorylatable residue frequently in the vicinity of the prolines. When decorated by phosphorylation, the serines and threonines that flank selected PPxY cores of WW domain ligands have the ability to positively or negatively regulate the binding (Korosi, T., Chang, A., and Sudol, M., unpublished results). Very recently, WW domains of two proteins, Ess1/Pin1 and Nedd-4, were shown to recognize phosphoserine or phosphothreonine containing ligands (Table 1) in a phosphorylation-dependent manner (62) . It is likely that, in addition to the PPxY binding pocket, these WW domains may have another crevice that accommodates the phosphoserine or phosphothreonine residues. It remains to be determined how phosphorylation affects the ligand binding of the 160 WW domains known so far.

It has also been shown that phosphorylation changes the cis/trans interconversion rate of the peptide bonds between serine/threonine and proline. A candidate enzyme is the peptidyl-prolyl cis/trans isomerase, Ess1/Pin1, which catalyzes the isomerization of phosphorylated Ser/Thr-Pro (110) . This activity is essential for progression through the cell cycle (111 , 112) and restoration of the microtubule-binding activity of {tau}, a protein component of neurofibrillar tangles of Alzheimer’s patients (113) . Peptide bond isomerization could alter binding either directly, by changing the shape of the ligand, or indirectly, by affecting enzyme-catalyzed hydrolysis of the bond. Therefore, it will be of great interest when the 3-dimensional structures of the Ess1/Pin1 WW domain complexed with its phosphorylated ligands (59 , 62) are determined.

Proline can have several other specific functions in proteins unrelated to the theme of binding elaborated here. Proline can induce ß-turns, particularly if preceded by tyrosine (114) or followed by phenylalanine or tryptophan residues (115) . Proline can also introduce bends in transmembrane helices, and because of its rigidity can act as a conformational ‘switch’, allowing parts of proteins to adopt alternative conformations such as domain-swapped dimers (116) .


   POLYPROLINE PEPTIDOMIMETICS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
With the elucidation of peptide sequences that bind to specific domains, it should be possible to use peptide ligands to interfere with specific SH3 domains in the cells. Ligands for the SH3 domains of Src and Lyn have been injected into oocytes (23) or electroporated into mast cells (117) and led to a biological response (i.e., acceleration of progesterone stimulated oocyte maturation, inhibition of mast cell activation). Although most peptides fail to cross the membrane on their own, in the future it should be possible to link them to peptide segments of Antennapedia (118 119 120) , Kaposi fibroblast growth factor (121) , or HIV Tat (122) , which do have the capacity to cross the plasma membrane. Recently, such an approach has been used to introduce a dimeric peptide segment of Sos into fibroblasts where it was observed to block the endogenous Ras signaling pathway (123) . Work from the laboratory of Stephan Feller (University of Wurtzburg) has shown that a high-affinity peptide ligand for the NH2-terminal SH3 domain of Crk, when attached to a cell permeable peptide sequence, has biological activity when added to tissue culture cells (Kardinal, C., and Feller, S., unpublished observation).

A number of proline-rich peptides, which are antimicrobial and adopt a PP II conformation, such as indolicidin (124) and bactenecin (125) , likely act by crossing cell membranes on their own. When neutrophils are incubated with the PR-39 peptide, a proline- and arginine-rich antimicrobial peptide, NADPH oxidase production of superoxide anion O2- is blocked. The peptide is presumed to act by binding to the SH3 domains of the NADPH oxidase subunits, thereby blocking assembly of a functional enzyme (126) . Furthermore, when NIH 3T3 cells are incubated with the 15 residue NH2-terminal segment of PR-39, the peptide crosses the membrane and binds SH3 domain-containing proteins, such as p130Cas (127) .

There has been great interest in designing peptidomimetic antagonists of protein-protein interactions. Such antagonists should have value in disrupting specific protein–protein interactions in the cell for the purposes of evaluating the functional consequences of the interaction and drug discovery. Stuart Schreiber and colleagues (Harvard University) have attempted to design inhibitors of the Src SH3 domain by initially synthesizing a library of compounds that contained nonpeptidic elements fused to the NH2 terminus of the core sequence PLPPLP. A combinatorial library of compounds, which was synthesized on beads, was incubated with a biotinylated Src SH3 domain, and positive beads were revealed when incubated with streptavidin-linked alkaline phosphatase and a chromogenic substrate. Only those beads with nonpeptidic elements that fit into the specificity pocket of the Src SH3 domain yielded positive beads, because the Kd of the PLPPLP peptide by itself is 1 mmol/l (128 , 129) . One ligand was selected for further development. Through screening a second-generation ‘tuning library’, ligands with nonpeptidic elements were identified that fit the specificity (130) and LP pockets (33) .

Other research groups have attempted to create peptidomimetics of the scaffolding prolines of SH3 ligands. This could have major consequences for drug design, because it allows a search for novel functionalities to replace the proline that can interact with new regions of the SH3 and hence enhance binding. Novel oligomers containing proline analogs have been observed to adopt a PP II conformation (131 , 132) . It also appears to be possible to replace proline by other N-substituted amino acids. Recently, a paper from the laboratory of Wendell Lim (University of California, San Francisco) demonstrated that the two prolines in the PxxP motif could tolerate substitution by N-substituted glycine, or ‘peptoid’, residues (133) . From a survey of six SH3 domain-peptide ligand pairs, N-substituted ligands were discovered to bind better than the original peptides. In particular, one ligand was identified that selectively bound the NH2-terminal SH3 domain of Grb2 with 100-fold greater affinity than the original 12-mer peptide sequence. Thus, in conjunction with cell permeable peptides, it may be possible in the future to generate peptidomimetics that are potent antagonists of specific SH3 and WW domain based protein–protein interactions in cultured cells and whole animals.


   FUTURE PROSPECTS
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 
Availability of complete genomes and proteomes makes it attractive to analyze a defined number of domains and to predict their cognate ligands and biochemical/genetic interactions. For example, computer analysis of the Saccharomyces cerevisiae and Caenorhabditis elegans genomes has revealed that they contain potentially 23 and 54 SH3 domain- and 6 and 10 WW domain-containing proteins, respectively. These domains are currently being analyzed in terms of their ligand predilections, using phage-displayed combinatorial peptide libraries, so that the optimal ligand sequences can be used to identify putative interacting proteins in either the yeast or nematode proteomes. Once the rules of the ‘protein recognition code’ (81) are more defined and the structural determinants of the domains are illuminated, one should be able to make such predictions with the aid of computer modeling/simulation packages. Such analyses could provide useful paradigms for analogous future approaches directed toward characterizing the human proteome.


   ACKNOWLEDGMENTS
 
Supported by grants from the Leukemia Society of America, Muscular Dystrophy Association, and the NIH. We would like to thank Trevor Creamer, Michael Eck, Xavier Espanel, Stephan Feller, Sam Gellman, Jeremy Kasanov, and James Morken for helpful comments on the manuscript. B. K. K. dedicates this review in memory of his father.


   FOOTNOTES
 
2 The FASEB Journal cannot guarantee the availability of references to the Web.


   REFERENCES
TOP
ABSTRACT
SH3 DOMAINS
WW DOMAINS
OTHER MODULES/PROTEINS THAT BIND...
BIOPHYSICAL REASONS WHY PROLINE...
THE REGULATION OF PROLINE...
POLYPROLINE PEPTIDOMIMETICS
FUTURE PROSPECTS
REFERENCES
 

  1. Geysen, H. M., Barteling, S. J., Meloen, R. H. (1985) Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. USA 82,178-182[Abstract/Free Full Text]
  2. Cohen, G. B., Ren, R., Baltimore, D. (1995) Modular binding domains in signal transduction proteins. Cell 80,237-248[Medline]
  3. Reuther, G. W., Pendergast, A. M. (1996) The roles of 14–3-3 proteins in signal transduction. Vitam. Horm. 52,149-175[Medline]
  4. Sudol, M. (1996) Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65,113-132[Medline]
  5. Di Fiore, P. P., Pelicci, P. G., Sorkin, A. (1997) EH: a novel protein-protein interaction domain potentially involved in intracellular sorting. Trends Biochem. Sci. 22,411-413[Medline]
  6. Pawson, T., Scott, J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278,2075-2080[Abstract/Free Full Text]
  7. Shoelson, S. E. (1997) SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr. Opin. Chem. Biol. 1,227-234[Medline]
  8. Ponting, C. P., Aravind, L., Schultz, J., Bork, P., Koonin, E. V. (1999) Eukaryotic signalling domain homologues in archaea and bacteria. Ancient ancestry and horizontal gene transfer. J. Mol. Biol. 289,729-745[Medline]
  9. Koch, C., Anderson, D., Moran, M., Ellis, C., Pawson, T. (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252,668-674[Abstract/Free Full Text]
  10. Bar-Sagi, D., Rotin, D., Batzer, A., Mandiyan, V., Schlessinger, J. (1993) SH3 domains direct cellular localization of signaling molecules. Cell 74,83-91[Medline]
  11. Seidel-Dugan, C., Meyer, B. E., Thomas, S. M., Brugge, J. S. (1992) Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12,1835-1845[Abstract/Free Full Text]
  12. Franz, W. M., Berger, P., Wang, J. Y. (1989) Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J 8,137-147[Medline]
  13. Jackson, P., Baltimore, D. (1989) N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8,449-456[Medline]
  14. Cicchetti, P., Mayer, B. J., Thiel, G., Baltimore, D. (1992) Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257,803-806[Abstract/Free Full Text]
  15. Ren, R., Mayer, B. J., Cicchetti, P., Baltimore, D. (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259,1157-1161[Abstract/Free Full Text]
  16. Alexandropoulos, K., Cheng, G., Baltimore, D. (1995) Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92,3110-3114[Abstract/Free Full Text]
  17. Knudsen, B. S., Feller, S. M., Hanafusa, H. (1994) Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J. Biol. Chem. 269,32781-32787[Abstract/Free Full Text]
  18. Schumacher, C., Knudsen, B. S., Ohuchi, T., Di Fiore, P. P., Glassman, R. H., Hanafusa, H. (1995) The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J. Biol. Chem. 270,15341-15347[Abstract/Free Full Text]
  19. Feller, R., Ren, R., Hanafusa, H., Baltimore, D. (1994) SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19,453-458[Medline]
  20. Mayer, B. J., Eck, M. J. (1995) SH3 domains: minding your p’s and q’s. Curr. Biol. 5,364-367[Medline]
  21. Chen, J. K., Lane, W. S., Brauer, A. W., Tanaka, A., Schreiber, S. L. (1993) Biased combinatorial libraries: novel ligands for the SH3 domain of phosphatidylinositol 3-kinase. J. Am. Chem. Soc. 115,12591-12952
  22. Cheadle, C., Ivashchenko, Y., South, V., Searfoss, G. H., French, S., Howk, R., Ricca, G. A., Jaye, M. (1994) Identification of a Src SH3 domain binding motif by screening a random phage display library. J. Biol. Chem. 269,24034-24039[Abstract/Free Full Text]
  23. Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., Zoller, M. J. (1994) Identification of Src, Fyn, Lyn, PI3K, and Abl SH3 domain ligands using phage display libraries. EMBO J 13,5598-5604[Medline]
  24. Sparks, A. B., Quilliam, L. A., Thorn, J. M., Der, C. J., Kay, B. K. (1994) Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J. Biol. Chem. 269,23853-23856[Abstract/Free Full Text]
  25. Bunnell, S. C., Henry, P. A., Kolluri, R., Kirchhausen, T., Rickles, R. J., Berg, L. J. (1996) Identification of Itk/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271,25646-25656[Abstract/Free Full Text]
  26. Quilliam, L. A., Lambert, Q. T., Westwick, J. K., Mickeslon-Young, L. A., Sparks, A. B., Kay, B. K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Der, C. J. (1996) Isolation of a Nck-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signalling. J. Biol. Chem. 271,28772-28775[Abstract/Free Full Text]
  27. Sparks, A., Rider, J., Hoffman, N., Fowlkes, D., Quilliam, L., Kay, B. (1996) Distinct ligand preferences of SH3 domains from Src, Yes, Abl, cortactin, p53BP2, PLC{gamma}, Crk, and Grb2. Proc. Natl. Acad. Sci. USA 93,1540-1544[Abstract/Free Full Text]
  28. Grabs, D., Slepnev, V. I., Songyang, Z., David, C., Lynch, M., Cantley, L. C., De Camilli, P. (1997) The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J. Biol. Chem. 272,13419-13425[Abstract/Free Full Text]
  29. Feng, S., Chen, J., Yu, H., Simmon, J., Schreiber, S. (1994) Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266,1241-1247[Abstract/Free Full Text]
  30. Lim, W. A., Richards, F. M., Fox, R. (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature (London) 372,375-379[Medline]
  31. Saraste, M., Musacchio, A. (1994) Backwards and forwards binding. Nat. Struct. Biol. 1,835-837[Medline]
  32. Posern, G., Zheng, J., Knudsen, B. S., Kardinal, C., Muller, K. B., Voss, J., Shishido, T., Cowburn, D., Cheng, G., Wang, B., Kruh, G. D., Burrell, S. K., Jacobson, C. A., Lenz, D. M., Zamborelli, T. J., Adermann, K., Hanafusa, H., Feller, S. M. (1998) Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene 16,1903-1912[Medline]
  33. Lee, C.-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., Sakesla, K. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14,5006-5015[Medline]
  34. Morken, J., Kapoor, T., Feng, S., Shirai, F., Schreiber, S. (1998) Exploring the leucine-proline binding procket to the Src SH3 domain using structure-based, split-pool synthesis and affinity selection. J. Am. Chem. Soc. 120,30-36
  35. Feng, S., Kasahara, C., Rickles, R. J., Schreiber, S. L. (1995) Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. USA 92,12408-12415[Abstract/Free Full Text]
  36. Gorina, S., Pavletich, N. P. (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274,1001-1005[Abstract/Free Full Text]
  37. Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., Schneider, C. (1997) A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. Proc. Natl. Acad. Sci. USA 94,4675-4680[Abstract/Free Full Text]
  38. Kishan, K. V., Scita, G., Wong, W. T., Di Fiore, P. P., Newcomer, M. E. (1997) The SH3 domain of Eps8 exists as a novel intertwined dimer. Nat. Struct. Biol. 4,739-743[Medline]
  39. Mongiovi, A. M., Romano, P. R., Panni, S., Mendoza, M., Wong, W. T., Musacchio, A., Cesareni, G., Paolo Di Fiore, P. (1999) A novel peptide–SH3 interaction. EMBO J 18,5300-5309[Medline]
  40. Zhao, H., Okada, S., Pessin, J. E., Koretzky, G. A. (1998) Insulin receptor-mediated dissociation of Grb2 from Sos involves phosphorylation of Sos by kinase(s) other than extracellular signal- regulated kinase. J. Biol. Chem. 273,12061-12067[Abstract/Free Full Text]
  41. Wu, Y., Spencer, S. D., Lasky, L. A. (1998) Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. J. Biol. Chem. 273,5765-5770[Abstract/Free Full Text]
  42. Comer, A. R., Ahern-Djamali, S. M., Juang, J. L., Jackson, P. D., Hoffmann, F. M. (1998) Phosphorylation of Enabled by the Drosophila Abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of Enabled. Mol. Cell. Biol. 18,152-160[Abstract/Free Full Text]
  43. Appella, D., Christianson, L., Karle, I., Powell, D., Gellman, S. (1996) ß-peptide foldamers: robust helix formation in a new family of ß-amino acid oligomers. J. Am. Chem. Soc. 118,13071-13072
  44. Nguyen, J. T., Lim, W. A. (1997) How Src exercises self-restraint. Nat. Struct. Biol. 4,256-260[Medline]
  45. Parrini, M. C., Mayer, B. J. (1999) Engineering temperature-sensitive SH3 domains. Chem. Biol. 6,679-687[Medline]
  46. Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., Wierenga, R. K. (1997) The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274,757-775[Medline]
  47. Xu, W., Harrison, S. C., Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature (London) 385,595-602[Medline]
  48. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C. H., Kuriyan, J., Miller, W. T. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature (London) 385,650-653[Medline]
  49. Sicheri, F., Moarefi, I., Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature (London) 385,602-609[Medline]
  50. Barila, D., Superti-Furga, G. (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18,280-282[Medline]
  51. Williams, J. C., Wierenga, R. K., Saraste, M. (1998) Insights into Src kinase functions: structural comparisons. Trends Biochem. Sci. 23,179-184[Medline]
  52. Jackson, P. K., Paskind, M., Baltimore, D. (1993) Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene 8,1943-1956[Medline]
  53. Andreotti, A. H., Bunnell, S. C., Feng, S., Berg, L. J., Schreiber, S. L. (1997) Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature (London) 385,93-97[Medline]
  54. Bork, P., Sudol, M. (1994) The WW domain: a signalling site in dystrophin?. Trends Biochem. Sci 19,531-533[Medline]
  55. Chen, H. I., Sudol, M. (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA 92,7819-7823[Abstract/Free Full Text]
  56. Macias, M. J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., Oschkinat, H. (1996) Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature (London) 382,646-649[Medline]
  57. Sudol, M. (1996) The WW module competes with the SH3 domain?. Trends Biochem. Sci. 21,161-163[Medline]
  58. Bedford, M. T., Chan, D. C., Leder, P. (1997) FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J 16,2376-2383[Medline]
  59. Linn, H., Ermekova, K. S., Rentschler, S., Sparks, A. B., Kay, B. K., Sudol, M. (1997) Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP. Biol. Chem. 378,531-537[Medline]
  60. Bedford, M. T., Reed, R., Leder, P. (1998) WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc. Natl. Acad. Sci. USA 95,10602-10607[Abstract/Free Full Text]
  61. Ranganathan, R., Lu, K. P., Hunter, T., Noel, J. P. (1997) Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89,875-886[Medline]
  62. Ibragimova, G. T., Wade, R. C. (1998) Importance of explicit salt ions for protein stability in molecular dynamics simulation. Biophys. J. 74,2906-2911[Abstract/Free Full Text]
  63. Mosser, E. A., Kasanov, J. D., Forsberg, E. C., Kay, B. K., Ney, P. A., Bresnick, E. H. (1998) Physical and functional interactions between the transactivation domain of the hematopoietic transcription factor NF-E2 and WW domains. Biochemistry 37,13686-13695[Medline]
  64. Lu, P. J., Zhou, X. Z., Shen, M., Lu, K. P. (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283,1325-1328[Abstract/Free Full Text]
  65. Chen, H. I., Einbond, A., Kwak, S. J., Linn, H., Koepf, E., Peterson, S., Kelly, J. W., Sudol, M. (1997) Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J. Biol. Chem. 272,17070-17077[Abstract/Free Full Text]
  66. Einbond, A., Sudol, M. (1996) Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Letters 384,1-8[Medline]
  67. Ermekova, K. S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., Sudol, M. (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272,32869-32877[Abstract/Free Full Text]
  68. Schild, L., Lu, Y., Gautschi, I., Schneeberger, E., Lifton, R. P., Rossier, B. C. (1996) Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J 15,2381-2387[Medline]
  69. Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., Rotin, D. (1996) WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle’s syndrome. EMBO J 15,2371-2380[Medline]
  70. Faber, P. W., Barnes, G. T., Srinidhi, J., Chen, J., Gusella, J. F., MacDonald, M. E. (1998) Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet. 7,1463-1474[Abstract/Free Full Text]
  71. Rentschler, S., Linn, H., Deininger, K., Bedford, M. T., Espanel, X., Sudol, M. (1999) The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. Biol. Chem. 380,431-442[Medline]
  72. Hansson, J. H., Schild, L., Lu, Y., Wilson, T. A., Gautschi, I., Shimkets, R., Nelson-Williams, C., Rossier, B. C., Lifton, R. P. (1995) A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc. Natl. Acad. Sci. USA 92,11495-11499[Abstract/Free Full Text]
  73. Tamura, H., Schild, L., Enomoto, N., Matsui, N., Marumo, F., Rossier, B. C. (1996) Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene. J. Clin. Invest. 97,1780-1784[Medline]
  74. Inoue, J., Iwaoka, T., Tokunaga, H., Takamune, K., Naomi, S., Araki, M., Takahama, K., Yamaguchi, K., Tomita, K. (1998) A family with Liddle’s syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel. J. Clin. Endocrinol. Metab. 83,2210-2213[Abstract/Free Full Text]
  75. Kumar, S., Tomooka, Y., Noda, M. (1992) Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Comm. 185,1155-1161[Medline]
  76. Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A., Schild, L., Rotin, D. (1997) Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J 16,6325-6336[Medline]
  77. Matsumoto, P. S., Ohara, A., Duchatelle, P., Eaton, D. C. (1993) Tyrosine kinase regulates epithelial sodium transport in A6 cells. Am. J. Physiol. 264,C246-C250[Abstract/Free Full Text]
  78. Shimkets, R. A., Lifton, R., Canessa, C. M. (1998) In vivo phosphorylation of the epithelial sodium channel. Proc. Natl. Acad. Sci. USA 95,3301-3305[Abstract/Free Full Text]
  79. Gavva, N. R., Gavva, R., Ermekova, K., Sudol, M., Shen, C. J. (1997) Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II. J. Biol. Chem. 272,24105-24108[Abstract/Free Full Text]
  80. Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y., Ito, Y. (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18,2551-2562[Medline]
  81. Komuro, A., Saeki, M., Kato, S. (1999) Npw38, a novel nuclear protein possessing a WW domain capable of activating basal transcription. Nucleic Acids Res 27,1957-1965[Abstract/Free Full Text]
  82. Waragai, M., Lammers, C. H., Takeuchi, S., Imafuku, I., Udagawa, Y., Kanazawa, I., Kawabata, M., Mouradian, M. M., Okazawa, H. (1999) PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8,977-987[Abstract/Free Full Text]
  83. Sudol, M. (1998) From Src Homology domains to other signaling modules: proposal of the ‘protein recognition code’. Oncogene 17,1469-1474[Medline]
  84. Reinhard, M., Rudiger, M., Jockusch, B. M., Walter, U. (1996) VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs. FEBS Lett 399,103-107[Medline]
  85. Gertler, F. B., Niebuhr, K., Reinhard, M., Wehland, J., Soriano, P. (1996) Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87,227-239[Medline]
  86. Niebuhr, K., Ebel, F., Frank, R., Reinhard, M., Domann, E., Carl, U. D., Walter, U., Gertler, F. B., Wehland, J., Chakraborty, T. (1997) A novel proline-rich motif present in ActA of listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J 16,5433-5444[Medline]
  87. Symons, M., Derry, J., Karlak, B., Jiang, S., Lemahieu, V., McCormick, F., Francke, U., Abo, A. (1996) Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84,723-734[Medline]